Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of celecoxib 400 mg capsule versus CELEBREX in healthy Thai volunteers under fasting conditions
TCTR20190318001Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib in pain and Inflammatory Disorders (2 arms), sponsored by Bio-innova. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
celecoxib
03
Conditions
painInflammatory Disorders
Beyond the preview
Go deeper on TCTR20190318001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190318001.